Orphan drugs in Australia

被引：6
|
作者：
Herkes, Geoffrey K. [1 ,2 ,3 ]
机构：
[1] Royal North Shore Hosp, Dept Neurol, St Leonards, NSW, Australia
[2] Univ Sydney, Kolling Inst, Med, Sydney, NSW, Australia
[3] Advisory Comm Prescript Med Therapeut Goods Adm, Canberra, ACT, Australia
来源：
EXPERT OPINION ON ORPHAN DRUGS | 2016年 / 4卷 / 12期
关键词：
Orphan drug program; review; rare diseases; oncology;
D O I：
10.1080/21678707.2016.1257383
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1195 / 1197
页数：3
相关论文
共 50 条
  • [31] Estimating the clinical cost of drug development for orphan versus non-orphan drugs
    Kavisha Jayasundara
    Aidan Hollis
    Murray Krahn
    Muhammad Mamdani
    Jeffrey S. Hoch
    Paul Grootendorst
    Orphanet Journal of Rare Diseases, 14
  • [32] Pricing and reimbursement of orphan drugs: the need for more transparency
    Simoens, Steven
    ORPHANET JOURNAL OF RARE DISEASES, 2011, 6
  • [33] Clinical experience with orphan drugs for rare metabolic diseases
    Caso-Gonzalez, Alicia
    Nunez-Rodriguez, Jesica
    Nebot-Villacampa, Maria-Jose
    Gonzalez-Perez, Yared
    Marin-Gorricho, Raquel
    Leralta-Gonzalez, Claudia
    Obaldia-Alana, Carmen
    ANALES DE PEDIATRIA, 2022, 96 (01): : 8 - 16
  • [34] Implementation status of pharmacological studies in the development of orphan drugs
    Yokoshiki, Saki
    Arato, Teruyo
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [35] Uptake of orphan drugs in the WHO essential medicines lists
    Costa, Enrico
    Moja, Lorenzo
    Wirtz, Veronika J.
    van den Ham, Hendrika A.
    Huttner, Benedikt
    Magrini, Nicola
    Leufkens, Hubert G. M.
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2024, 102 (01) : 22 - 31
  • [36] Analysis of the real availability of the orphan drugs in the Slovak Republic
    Kuzelova, M.
    Ondriasova, E.
    Foltanova, T.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 406 - 407
  • [37] Affordable orphan drugs: a role for not-for-profit organizations
    Davies, Elin H.
    Fulton, Emma
    Brook, Daniel
    Hughes, Dyfrig A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (07) : 1595 - 1601
  • [38] Implementation status of pharmacological studies in the development of orphan drugs
    Saki Yokoshiki
    Teruyo Arato
    Orphanet Journal of Rare Diseases, 19
  • [39] Variables affecting pricing of orphan drugs: the Italian case
    Jommi, Claudio
    Listorti, Elisabetta
    Villa, Federico
    Ghislandi, Simone
    Genazzani, Armando
    Cangini, Agnese
    Trotta, Francesco
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [40] Orphan drugs: some legal, ethical and economics aspects
    Pabst, JY
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2001, 49 (04): : 387 - 396
12345